Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
Abbott
ABT
|
$1.12B |
| 2 |
Kellanova
K
|
$900M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$727M |
| 4 |
Wells Fargo
WFC
|
$704M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$609M |
Top Sells
| 1 |
Amgen
AMGN
|
$1.34B |
| 2 |
Canadian Natural Resources
CNQ
|
$982M |
| 3 |
Crown Castle
CCI
|
$905M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$867M |
| 5 |
McKesson
MCK
|
$835M |
Sector Composition
| 1 | Healthcare | 16.44% |
| 2 | Technology | 15.01% |
| 3 | Financials | 11.47% |
| 4 | Consumer Discretionary | 10.69% |
| 5 | Communication Services | 10.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
BioMarin Pharmaceuticals
BMRN
$11.2B
| $1.72B | 0.54% | 19,643,433 +390 | +0% | +$34.2K |
|
52
Freeport-McMoran
FCX
$63.7B
| $1.72B | 0.54% | 128,723,380 -20,709,396 | -14% | -$277M |
|
53
Berkshire Hathaway Class B
BRK.B
$1.09T
| $1.69B | 0.53% | 10,160,842 +257,709 | +3% | +$43M |
|
54
UBS Group
UBS
$128B
| $1.63B | 0.52% | 102,134,430 -7,118,687 | -7% | -$114M |
|
55
IBM
IBM
$227B
| $1.54B | 0.48% | 8,816,671 -995,215 | -10% | -$173M |
|
56
Goldman Sachs
GS
$226B
| $1.53B | 0.48% | 6,652,625 -2,484,665 | -27% | -$571M |
|
57
Costco
COST
$418B
| $1.52B | 0.48% | 9,073,570 -166,601 | -2% | -$27.9M |
|
58
Microsoft
MSFT
$3.77T
| $1.47B | 0.46% | 22,309,799 -189,406 | -0.8% | -$12.5M |
|
59
Gilead Sciences
GILD
$140B
| $1.46B | 0.46% | 21,474,531 -3,298,010 | -13% | -$224M |
|
|
60
Abbott
ABT
$231B
| $1.45B | 0.46% | 32,671,625 +25,159,924 | +335% | +$1.12B |
|
61
Prudential Financial
PRU
$38.6B
| $1.44B | 0.45% | 13,499,840 +1,454,535 | +12% | +$155M |
|
|
VALE.P
62
DELISTED
Vale S A
VALE.P
| $1.41B | 0.44% | 156,976,282 -26,626,151 | -15% | -$239M |
|
63
McDonald's
MCD
$224B
| $1.36B | 0.43% | 10,486,587 -613,416 | -6% | -$79.5M |
|
64
Western Union
WU
$2.8B
| $1.33B | 0.42% | 65,378,098 +31,185 | +0% | +$635K |
|
|
NLSN
65
DELISTED
Nielsen Holdings plc
NLSN
| $1.3B | 0.41% | 31,359,204 +3,635,373 | +13% | +$150M |
|
66
Qorvo
QRVO
$8.4B
| $1.26B | 0.4% | 18,317,530 | – | – |
|
|
PXD
67
DELISTED
Pioneer Natural Resource Co.
PXD
| $1.25B | 0.39% | 6,687,003 -895,000 | -12% | -$167M |
|
68
Mastercard
MA
$538B
| $1.23B | 0.39% | 10,956,410 +91,159 | +0.8% | +$10.3M |
|
69
Chevron
CVX
$324B
| $1.22B | 0.39% | 11,390,950 -2,812,315 | -20% | -$302M |
|
|
70
McKesson
MCK
$85.4B
| $1.22B | 0.38% | 8,228,633 -5,630,295 | -41% | -$835M |
|
71
Exelon
EXC
$44.1B
| $1.22B | 0.38% | 33,899,154 -1,861,579 | -5% | -$67M |
|
72
Nike
NKE
$114B
| $1.22B | 0.38% | 21,860,527 +3,400 | +0% | +$189K |
|
73
Truist Financial
TFC
$60.4B
| $1.2B | 0.38% | 26,899,185 +10,146,305 | +61% | +$454M |
|
74
Schlumberger
SLB
$55B
| $1.13B | 0.36% | 14,466,187 +3,441,288 | +31% | +$269M |
|
|
75
Kellanova
K
$27.6B
| $1.13B | 0.36% | 15,536,014 +12,400,257 | +395% | +$900M |
|